Cortes, Jorge E. http://orcid.org/0000-0002-8636-1071
Apperley, Jane F.
DeAngelo, Daniel J.
Deininger, Michael W.
Kota, Vamsi K.
Rousselot, Philippe
Gambacorti-Passerini, Carlo
Funding for this research was provided by:
Pfizer (NA)
Article History
Received: 23 October 2018
Accepted: 9 December 2018
First Online: 27 December 2018
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: J.E.C. has received consultancy fees from Pfizer, Novartis, Forma Therapeutics, Daiichi, and Astellas, and research funding from Pfizer, Novartis, Forma Therapeutics, Daiichi, and Astellas.J.F.A. has received honoraria from ARIAD, Bristol-Myers Squibb, Incyte, MSD, Novartis, and Pfizer, and has received research funding from ARIAD, Novartis and Pfizer.D.J.D. has served in a consulting or advisory role for Amgen, ARIAD, Bristol-Myers Squibb, Incyte, Novartis, and Pfizer, and has received research funding from ARIAD.M.W.D. has served in a consulting or advisory role for ARIAD, Bristol-Myers Squibb, Incyte, Novartis, and Pfizer; has received travel, accommodations, or other expense reimbursements from ARIAD, Bristol-Myers Squibb, CTI BioPharma, Novartis, and Pfizer; has provided expert testimony for Bristol-Myers Squibb; has received honoraria from ARIAD, Bristol-Myers Squibb, CTI BioPharma, Incyte, Novartis, and Pfizer; and has received research funding from ARIAD, Bristol-Myers Squibb, Celgene, Incyte, and Novartis.V.K.K. has received consultancy fees from ARIAD, Pfizer, Xcenda, Bristol-Myers Squibb, and Incyte.P.R. reports research funding from Pfizer.C.G.-P. has served in an advisory role to Bristol-Myers Squibb and Pfizer and has received research funding from ARIAD.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.